BWXTBWX Technologies, Inc.

NYSE bwxt.com


$ 102.09 $ 1.39 (1.38 %)    

Friday, 23-Aug-2024 15:59:56 EDT
QQQ $ 479.76 $ 5.15 (1.08 %)
DIA $ 411.97 $ 4.35 (1.07 %)
SPY $ 562.00 $ 5.91 (1.06 %)
TLT $ 98.37 $ 0.64 (0.65 %)
GLD $ 231.99 $ 2.65 (1.16 %)
$ 102.08
$ 102.02 x 200
-- x --
-- - --
$ 70.81 - $ 106.39
393,633
na
9.33B
$ 0.74
$ 34.87
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-01-2021 09-30-2021 10-Q
13 08-02-2021 06-30-2021 10-Q
14 05-03-2021 03-31-2021 10-Q
15 02-22-2021 12-31-2020 10-K
16 11-02-2020 09-30-2020 10-Q
17 08-03-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 02-24-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-05-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-25-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-04-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 10-31-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-02-2016 03-31-2016 10-Q
35 02-24-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 11-05-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 deutsche-bank-maintains-buy-on-bwx-technologies-raises-price-target-to-113

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and raises the price target from $112...

 bwx-technologies-q2-2024-adj-eps-082-beats-075-estimate-sales-681465m-beat-639313m-estimate

BWX Technologies (NYSE:BWXT) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.75 ...

 barclays-downgrades-bwx-technologies-to-underweight-raises-price-target-to-90

Barclays analyst David Strauss downgrades BWX Technologies (NYSE:BWXT) from Equal-Weight to Underweight and raises the price...

 northstar-medical-radioisotopes-bwxt-medical-sign-multi-year-master-services-agreement-which-will-facilitate-the-production-of-ac-225

Actinium-225 (Ac-225) is a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.

 bwxt-medical-and-northstar-partner-to-produce-cancer-fighting-isotope-ac-225

BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE:BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) toda...

 janney-montgomery-scott-initiates-coverage-on-bwx-technologies-with-buy-rating-announces-price-target-of-113

Janney Montgomery Scott analyst Thomas Meric initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating and announ...

 btig-initiates-coverage-on-bwx-technologies-with-buy-rating-announces-price-target-of-110

BTIG analyst Andre Madrid initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating and announces Price Target of...

 bwx-technologies-awarded-phase-two-microreactor-evaluation-contract-for-state-of-wyoming-20m-total-value-of-cost-share-program-and-phase-two-expected-completion-by-q3-2025

Support Strong Among Wyoming Stakeholders and Potential Vendors During Phase One of Cost-Share Program

Core News & Articles

BWX Technologies, Inc. (NYSE:BWXT) today announced a contract award from the U.S. Department of Energy, National Nuclear Securi...

 deutsche-bank-maintains-buy-on-bwx-technologies-lowers-price-target-to-107

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and lowers the price target from $110...

 jim-cramer-isnt-recommending-slb-and-blackberry-nothing-there

Jim Cramer is not going to recommend Schlumberger, as it has "got too much business that is not acting well right now."...

 bwx-technologies-submits-drug-master-file-to-us-food-and-drug-administration-for-no-carrier-added-actinium-225-active-pharmaceutical-ingredient

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n...

 clsa-initiates-coverage-on-bwx-technologies-with-buy-rating

CLSA analyst Max Hopkins initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating.

 deutsche-bank-maintains-buy-on-bwx-technologies-lowers-price-target-to-110

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and lowers the price target from $111...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION